EYPT   $10.72  -2.99% Market Closed After Close 10.7 -0.19%

EyePoint Pharmaceuticals Inc
Total Cash 280.25M
totalCashPerShare 5.236
EBITDA -96.53M
Total Debt 23.29M
quickRatio 4.535
currentRatio 4.749
Total Revenue 50.39M
debtToEquity 10.203
Revenue/Share 1.08
ROA -0.24359
ROE -0.60806
grossProfits
freeCashflow -33.15M
operatingCashflow -89.66M
earningsGrowth
revenueGrowth 0.041
grossMargins -0.54825
ebitdaMargins -1.91556
operatingMargins -3.6452498
profitMargins -1.72295
enterpriseValue 334.42M
forwardPE -3.375394
floatShares 35.86M
sharesOutstanding 53.52M
sharesShort 8.93M
sharesShortPriorMonth 9.11M
dateShortInterest
sharesPercentSharesOut 0.17%
heldPercentInsiders 0.01%
heldPercentInstitutions 1.11%
Short Ratio help_outline 14.75%
shortPercentOfFloat 0.20%
impliedSharesOutstanding
bookValue 4.377
Price To Book help_outline 2.44
earningsQuarterlyGrowth
netIncomeToCommon -86.82M
trailingEps -1.78%
forwardEps -3.17%
enterpriseToEbitda -3.46
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.55 3Q 2024
institutionsCount 215
lastUpdated Oct. 22, 2024, 3:30 a.m.